Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-04-11)Premium Content

Eli Lilly And Co (LLY)

2014-04-17@16:21:41 ET
Potential Eli Lilly (LLY) Trade Targets 3.11% Return (FBM)

2014-04-17@05:34:27 ET
Global Malignant Mesothelioma Clinical Trials Review 2014 - Profiles of 10 Companies & 9 Organisations (MTO)

2014-04-16@17:30:09 ET
Cocrystal Pharma, Inc. Announces Stock Symbol Change from BZNE to COCP (INW)

2014-04-16@11:26:09 ET
Global Neuroblastoma Clinical Trials Review 2014 - Analysis of 9 Companies (MTO)

2014-04-16@09:22:38 ET
Potential Eli Lilly (LLY) Trade Has 2.63% Downside Protection (FBM)

2014-04-15@14:45:02 ET
Eli Lilly (LLY) Showing Bullish Technicals (FBM)

2014-04-15@12:47:14 ET
Cocrystal Pharma, Inc. Announces Stock Symbol Change from BZNE to COCP (INW)

2014-04-15@10:10:22 ET
BMO Capital Made the Right Call, Eli Lilly 0.6% Higher (LLY) (F70)

2014-04-15@07:00:02 ET
Global Polycythemia Vera Therapeutic Pipeline Review 2014 - Analysis of 6 Companies and 7 Drug Profiles (MTO)

2014-04-15@06:54:48 ET
Global Fracture Therapeutic Pipeline Review Report 2014 (MTO)

2014-04-15@03:27:15 ET
Global Malignant Glioma Clinical Trials Review 2014 (MTO)

2014-04-15@01:06:49 ET
Lilly Schedules Conference Call for 1st Quarter 2014 Financial Results (CLM)

2014-04-14@20:58:13 ET
Eli Lilly & Co.Corporate Event Announcement Notice (WSH)

2014-04-14@12:51:51 ET
Healthcare Stocks Posting Moderate Gains; Lilly, Partner File NDA for Combination Tablet for Diabetes (MID)

2014-04-14@12:47:01 ET
Sector Update: Healthcare (MID)

2014-04-14@12:34:26 ET
Research and Markets: Global Depression Drugs Market 2014-2018 with GlaxoSmithKline plc, Eli Lilly & Co., Pfizer Inc., and Forest Laboratories Dominating (BIZ)

2014-04-14@12:00:59 ET
Bullish Moving Average Cross by Eli Lilly (LLY) (F78)

2014-04-14@11:34:57 ET
Global Depression Drugs Market 2014-2018 with GlaxoSmithKline plc, Eli Lilly & Co., Pfizer Inc., and Forest Laboratories Dominating (MTO)

2014-04-14@10:38:07 ET
Next Resistance Level for Eli Lilly (LLY) is $59.32 (F79)

2014-04-14@10:05:00 ET
Revera Board Appoints Thomas G. Wellner as President and Chief Executive Officer (CNW)